GlassScriptPhysician profile
Nicole Ambrose
NPI 1346801248
$3,287.06
in general payments reported to CMS, 2019-2025
19 companies · $59.24 in 2025
The $59.24 reported for 2025 was less than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $124 · 2020: $59.40 · 2021: $537 · 2022: $1,082 · 2023: $935 · 2024: $491 · 2025: $59.24.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,485.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,485.08 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $767.47 | 2021-2025 | Lithovue, Rezum Generator, Upsylon |
| Teleflex LLC | $391.11 | 2022-2024 | Urolift |
| Urogen Pharma, INC. | $372.23 | 2022-2023 | Jelmyto |
| Myovant Sciences INC. | $275.68 | 2021-2022 | |
| Medical Device Business Services, INC. | $244.70 | 2021-2022 | |
| Olympus America INC. | $222.80 | 2021-2022 | |
| Janssen Scientific Affairs, LLC | $182.95 | 2019-2022 | |
| Blue Earth Diagnostics | $130.62 | 2019-2021 | |
| Axonics, INC. | $118.92 | 2022 | |
| Abbvie INC. | $112.45 | 2024 | |
| Janssen Biotech, INC. | $111.72 | 2024 | Erleada, Akeega |
| Ethicon US, LLC | $92.67 | 2023 | Vistaseal, Surgicel Nu-Knit, Evarrest |
| Cook Medical LLC | $71.72 | 2024 | Cook |
| Dendreon Pharmaceuticals LLC | $59.40 | 2020 | |
| Astrazeneca Pharmaceuticals LP | $41.99 | 2022-2023 | Enhertu |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Calyxo, INC. | $26.11 | 2025 | Cvac Aspiration System |
| Astellas Pharma US INC | $23.36 | 2023 | Xtandi |
| Incyte Corporation | $22.49 | 2022 | |
| Novartis Pharmaceuticals Corporation | $18.67 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Nicole Ambrose listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.